OTTAWA, Ontario, Canada — Health Canada, the governmental organization who oversees the safety of medications and medical therapies in Canada, issued an urgent safety warning to people taking the intravenous drug BENLYSTA (belimumab) for SLE or systemic lupus erythematosus (lupus) could experience substantial mental health disorders … [Read more...] about Health Canada Issues Safety Alert for Lupus Drug

OTTAWA, Ontario, Canada — On April 4, 2019, Health Canada announced that the lupus drug BENLYSTA (belimumab) might cause depression, suicidal thoughts, or behavior that leads to self-injury. Health Canada warns physicians and patients battling lupus to be wary of any symptoms indicative of depression while taking BENLYSTA (belimumab) … [Read more...] about Lupus Medication Can Lead to Depression, Suicide